Additionally, histological analysis of tumor tissues revealed that melittin treatment resulted in a significant reduction in Bcl-2 levels and a concomitant increase in Bax levels (p < 0.05, p < 0.01, p < 0.001) (Figure 5B). The gene discussed is BCL2; the disease is neoplasm.